|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0027625,
umls-concept:C0030705,
umls-concept:C0087111,
umls-concept:C0150369,
umls-concept:C0278488,
umls-concept:C0439849,
umls-concept:C0445223,
umls-concept:C0871261,
umls-concept:C1513400,
umls-concept:C1514307,
umls-concept:C1518601,
umls-concept:C1550456,
umls-concept:C1552599,
umls-concept:C1704632,
umls-concept:C1704787,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2009-5-28
|
|
pubmed:abstractText |
We analyzed circulating tumor cells (CTC) in blood of metastatic breast cancer patients (n = 42) and determined the ability of this method to predict therapy response.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Cell Adhesion Molecules,
http://linkedlifedata.com/resource/pubmed/chemical/EPCAM protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/MUC1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Mucin-1,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1573-7217
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
115
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
581-90
|
|
pubmed:dateRevised |
2011-10-28
|
|
pubmed:meshHeading |
pubmed-meshheading:18679793-Adult,
pubmed-meshheading:18679793-Aged,
pubmed-meshheading:18679793-Antigens, Neoplasm,
pubmed-meshheading:18679793-Antineoplastic Agents,
pubmed-meshheading:18679793-Breast Neoplasms,
pubmed-meshheading:18679793-Carcinoma, Ductal, Breast,
pubmed-meshheading:18679793-Carcinoma, Lobular,
pubmed-meshheading:18679793-Carcinoma, Medullary,
pubmed-meshheading:18679793-Cell Adhesion Molecules,
pubmed-meshheading:18679793-Female,
pubmed-meshheading:18679793-Humans,
pubmed-meshheading:18679793-Immunoenzyme Techniques,
pubmed-meshheading:18679793-Middle Aged,
pubmed-meshheading:18679793-Mucin-1,
pubmed-meshheading:18679793-Neoplasm Staging,
pubmed-meshheading:18679793-Neoplastic Cells, Circulating,
pubmed-meshheading:18679793-Prognosis,
pubmed-meshheading:18679793-Prospective Studies,
pubmed-meshheading:18679793-RNA, Messenger,
pubmed-meshheading:18679793-Receptor, erbB-2,
pubmed-meshheading:18679793-Receptors, Estrogen,
pubmed-meshheading:18679793-Receptors, Progesterone,
pubmed-meshheading:18679793-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:18679793-Survival Rate,
pubmed-meshheading:18679793-Tumor Markers, Biological
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies.
|
|
pubmed:affiliation |
Department of Internal Medicine (Cancer Research), University Hospital Essen, University of Duisburg-Essen, 45122, Essen, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
